News | December 15, 2022
China aims to lead next bio revolution in advanced biologics, says GlobalData
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
Ayúdame3D has become a leading social entity in social technology.
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
LG Chem will receive totaling up to $95.5 million for the China rights
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
The investment will enable the company to enter European markets as well as enhance margins in current markets
To focus on providing safer burn treatments for women and armed forces
Subscribe To Our Newsletter & Stay Updated
